[Morphological characteristics of serous ovarian adenocarcinomas after chemotherapy].
作者信息
Serov S F, Irzhanov S I
出版信息
Vopr Onkol. 1980;26(3):37-40.
PMID:7368655
Abstract
The authors studied morphologically serous cystic adenocarcinomas of the ovary from 27 patients aged from 30 to 70 years. 100 patients were not given a preoperative course of chemotherapy, and 107 patients received different chemical drugs preoperatively. Changes in the mitotic activity indicate the sensitivity or resistance of the tumor to different chemical drugs.
摘要
相似文献
1
[Morphological characteristics of serous ovarian adenocarcinomas after chemotherapy].
Vopr Onkol. 1980;26(3):37-40.
2
3
[Mitotic activity in ovarian serous cystadenocarcinomas treated with thio-TEPA].[硫代磷酸三乙酯治疗卵巢浆液性囊腺癌的有丝分裂活性]
Akush Ginekol (Mosk). 1979 Dec(12):38-9.
4
[Characteristics of the dissemination process in patients with serous cystadenocarcinoma of the ovaries].
Vopr Onkol. 1984;30(8):83-6.
5
Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.
Am J Obstet Gynecol. 2006 Aug;195(2):568-74; discussion 574-6. doi: 10.1016/j.ajog.2006.03.075.
6
7
The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.伴有非侵袭性种植的卵巢浆液性交界性肿瘤的复发率和总生存率与时间相关。
Am J Surg Pathol. 2006 Nov;30(11):1367-71. doi: 10.1097/01.pas.0000213294.81154.95.
8
[Adjuvant treatment of cystadenocarcinoma].[囊腺癌的辅助治疗]
Rev Prat. 1989 Nov 11;39(26):2325-8.
9
[Prognostic factors and better survival rate after the treatment of advanced ovarian cancer with neoadjuvant chemotherapy].
Akush Ginekol (Sofiia). 2004;43(6):17-9.
10
Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.卵巢或腹膜低级别浆液性癌的新辅助化疗。
Gynecol Oncol. 2008 Mar;108(3):510-4. doi: 10.1016/j.ygyno.2007.11.013. Epub 2007 Dec 26.
Zotero 插件